Meeting the challenges of rare diseases in NHS newborn blood spot screening
Find out more about Blood Spot Task Group (BSTG) and how it is helping inform UK National Screening Committee (UK NSC) evaluations into screening for rare diseases.
Find out more about Blood Spot Task Group (BSTG) and how it is helping inform UK National Screening Committee (UK NSC) evaluations into screening for rare diseases.
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is scheduled to start from September 2021.
In 2015, the UK National Screening Committee (UK NSC) supported a pilot in England in order to understand how pulse oximetry screening on newborn babies would work in the NHS.
A look at Group B Streptococcus (GBS) and screening.